Rdcthera is dedicated to supporting the radiopharmaceutical industry by providing the latest CRO services. The tests offered are executed at a high professional level with key areas of expertise focused on BBB permeability tests, the most imperative of which are for radiopharmaceuticals targeted at brain tissues.
The blood-brain barrier is a highly selective permeability barrier that shields the brain from probable toxic substances but allows essential molecules, including oxygen and nutrients. Thus, crossing this barrier is crucial for radiopharmaceuticals targeting brain targets. A huge number of radiopharmaceuticals are incapable of passing through the BBB, either due to low solubility in the membrane bilayer or recognition and consequent efflux by efflux pumps like P-glycoprotein and breast cancer resistance protein. Therefore, the developmental steps of these compounds are reputed to be critical in evaluating permeability across the BBB.
Fig. 1. In vitro microfluidic-integrated BBB models. (Choi JH, et al., 2019)
At Rdcthera, we offer state-of-the-art in vitro blood-brain barrier permeability test services. Our experienced team utilizes sophisticated BBB models to evaluate the permeation of radiopharmaceuticals through the layers of cells without being affected by efflux pumps. We conduct cell-based assays to assess the susceptibility of compounds to efflux pumps and use in silico scoring systems to predict the likelihood of successful BBB penetration.
We make use of advanced in-vitro BBB models that physiologically represent the human brain. Our models are designed to
Our In Vitro BBB Models | |
|
|
|
|
|
|
The experimental methods are designed with good care to ensure proper and reproducible results.
Our services provide a wealth of data and insights, including
It is in such information, if derived from blood-brain barrier permeability testing, that can be of essence in the optimization of radiopharmaceutical design and in vivo behavior predictions, also in the selection of promising candidates for further development. Make informed decisions and accelerate the progress of your drug discovery projects through our services.
Feel free to contact us for more information regarding our services related to blood-brain barrier permeability testing and how we can further support radiopharmaceutical development.
Reference
Rdcthera offers efficient, customized, and professional R&D services related to radionuclide drug conjugates.